Home
10x Genomics TXG paid Tarplin, Downs & Young $80K for lobbying in Q2 2023 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q2 2023
- Stock
- 10x Genomics TXG
- Client
- 10X Genomics
- Reported
- 23/07/17
Up 0.0% from last quarter
What else happened in 10x Genomics around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/3010X Genomics's other lobbying reports
- 10X Genomics
Lobbying10x Genomics
Lobbying10x Genomics
TXG
$40K
$40K
Reported 24/01/20
for Q4 2023
- 10X Genomics
Lobbying10x Genomics
Lobbying10x Genomics
TXG
$80K
$80K
Reported 23/10/17
for Q3 2023
- 10X Genomics
Lobbying10x Genomics
Lobbying10x Genomics
TXG
$80K
$80K
Reported 23/04/18
for Q1 2023
- 10X Genomics
Lobbying10x Genomics
Lobbying10x Genomics
TXG
$80K
$80K
Reported 23/01/20
for Q4 2022